Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Current Deferred Revenue (2013 - 2022)

Talphera (TLPH) posted Current Deferred Revenue of $1.2 million for Q4 2022, down 3.6% on a QoQ basis from $1.2 million in Q3 2022, and down 6.95% year-over-year from $1.2 million in Q4 2021.

Analysis

Talphera (TLPH) Current Deferred Revenue (2013 - 2022) Analysis & Trends

Talphera has reported Current Deferred Revenue for 10 years, with the latest figure at $1.2 million in Q4 2022.

  • On a quarterly basis, Current Deferred Revenue fell 6.95% year-over-year to $1.2 million in Q4 2022; TTM through Dec 2022 was $1.2 million, a 6.95% decrease from a year earlier, with the FY2022 full-year figure at $1.2 million, down 6.95% from the prior year.
  • Current Deferred Revenue was $1.2 million for Q4 2022 at Talphera, down from $1.2 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $3.5 million in Q1 2019, with the low at $49000.0 in Q4 2020.
  • Average Current Deferred Revenue over 5 years is $1.6 million, with a median of $1.2 million recorded in 2021.
  • The sharpest annual moves came in 2020 and 2021: Current Deferred Revenue tumbled 98.49% in 2020, then jumped 2424.49% in 2021.
  • Over 5 years, Current Deferred Revenue stood at $3.5 million in 2018, then declined by 6.32% to $3.2 million in 2019, then sank by 98.49% to $49000.0 in 2020, then surged by 2424.49% to $1.2 million in 2021, then retreated by 6.95% to $1.2 million in 2022.
  • The last three Current Deferred Revenue figures came in at $1.2 million (Q4 2022), $1.2 million (Q3 2022), and $1.2 million (Q2 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.15 Mn
Sep 30, 2022 1.19 Mn
Jun 30, 2022 1.21 Mn
Mar 31, 2022 1.24 Mn
Dec 31, 2021 1.24 Mn
Sep 30, 2021 1.24 Mn
Dec 31, 2020 49,000.00
Sep 30, 2020 200,000.00
Jun 30, 2020 343,000.00
Mar 31, 2020 3.17 Mn
Dec 31, 2019 3.24 Mn
Sep 30, 2019 3.23 Mn
Jun 30, 2019 3.31 Mn
Mar 31, 2019 3.51 Mn
Dec 31, 2018 3.46 Mn
Sep 30, 2018 326,000.00
Jun 30, 2018 338,000.00
Mar 31, 2018 350,000.00
Dec 31, 2017 362,000.00
Sep 30, 2017 362,000.00